Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pain Recovery After Mastectomy
NCT03388814Phase 1Withdrawn
- Sponsor
- Wake Forest University Health Sciences
- Start
- Nov 2018
- Primary completion
- Jun 2020
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoint: Modeled worst pain intensity using the numeric rating scale (NRS) at 2 months. Planned start Nov 2018; status: withdrawn.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03388814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03388814.